Verano Holdings Corp (VRNO) Financials

VRNO Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.7 billion 1.0 billion
March 31, 2026 1.7 billion 1.0 billion
Dec. 31, 2025 1.8 billion 1.1 billion
Sept. 30, 2025 1.9 billion 1.0 billion

VRNO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 18.2 million 7.9 million
March 31, 2026 3.6 million ?
Dec. 31, 2025 4.5 million ?
Sept. 30, 2025 19.1 million ?

VRNO Net Income

No data available :(

VRNO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 85.2 million 382.1 million 88.5 million
March 31, 2026 74.3 million 385.5 million 89.4 million
Dec. 31, 2025 82.6 million 391.2 million 90.9 million
Sept. 30, 2025 82.5 million 397.4 million 92.9 million

VRNO Shares Outstanding

No data available :(

VRNO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 11.6 million - 87.5 million -
March 31, 2026 14.7 million - 81.0 million -
Dec. 31, 2025 9.6 million - 85.2 million -
Sept. 30, 2025 7.3 million - 74.8 million -

VRNO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 217.9 million 118.2 million
March 31, 2026 205.3 million 112.5 million
Dec. 31, 2025 223.2 million 101.1 million
Sept. 30, 2025 200.6 million 111.2 million

VRNO Revenue by Segment
Graph available only for paid members. Upgrade to see it.

VRNO

Price: $5.27

52 week price:
3.91
9.75

Earnings Per Share: -0.99 USD

P/E Ratio: -1.08

Exchange: OQX

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 388.8 million

Links: